The use of high-dose ifosfamide in the combined treatment of soft tissue sarcomas (first experience in the national center of oncology and hematology in bishkek)
Abstract
In our article the experience of treating patients with soft tissue sarcomas in the National Center of Oncology and Hematology is given. The purpose of the study was the use of modern methods of diagnosis and treatment of soft tissue sarcomas. For the first time in the Kyrgyz Republic, modern schemes of drug therapy were applied at the stage of combined treatment with the use of high-dose polychemotherapy regimens in the form of continuous 24-hour infusion. As a result of our study of patients with soft tissue sarcomas, mortality at the follow-up period from 8 to 35 months. was 46,2%, which corresponds to the average statistical data.
About the Authors
A. A. Babalaev
National Center of Oncology and Hematology
Kyrgyzstan
Kyrgyzstan
Bishkek
A. T. Alymkulov
National Center of Oncology and Hematology
Kyrgyzstan
Kyrgyzstan
Bishkek
T. A. Abdyldaev
National Center of Oncology and Hematology
Kyrgyzstan
Kyrgyzstan
Bishkek
R. T. Reshetin
National Center of Oncology and Hematology
Kyrgyzstan
Kyrgyzstan
Bishkek
U. A. Turgunbaev
National Center of Oncology and Hematology
Kyrgyzstan
Kyrgyzstan
Bishkek
D. K. Aydaralyeva
National Center of Oncology and Hematology
Kyrgyzstan
Kyrgyzstan
Bishkek
References
1. Алиев М.Д., Сушенцов Е.А. Современная онкоортопедия. Саркомы костей, мягких тканей и опухоли кожи. 2012, № 4, с. 3-10.
2. Давыдов М.И., Аксель Е.М. Статистика злокачественных новообразований в России и СНГ за 2012 год. Вестник РОНЦ им. Н.Н. Блохина. 2013, т. 22, № 3 (85) прил. 1., с. 54-92.
3. Чиссов В.И., Дарьялова С.Л. Онкология. ГЭОТАР-Медиа. 2006, с. 627-653.
4. Мерабишвили В.М., Щербук Ю.А. Онкологическая служба в Санкт-Петербурге и районах города в 2009 году. Ежегодник популяционного ракового регистра. СПб., 2010, № 16.
5. Alvegard T.A., Berg N.O. Histopathology peer review of high grade soft tissue sarcoma: The Scandinavian Sarcoma Group. J. Clin. Oncol. 1989, v. 7, р. 1845.
6. Greene F.L., Page D.L., Fleming I.D. et al. For the American Joint Committee on Cancer. AJCC cancer staging manual 6th ed. New York: Springer-Verlag. 2002.
7. Patel S.R., Benjamin R.S. Sarcomas: part I and II. Hematol. Oncol. Clin. North Am. 1995, v. 9, р. 513-942.
8. Горбунова В.А., Феденко А.А., Бохян Б.Ю., Истомин И.А., Губина Г.И. Высокодозный ифосфамид в комбинации с доксорубицином в лечении сарком мягких тканей. Саркомы костей, мягких тканей и опухоли кожи. 2010, № 1, с. 26-31.
Review
For citations:
Babalaev A.A., Alymkulov A.T., Abdyldaev T.A., Reshetin R.T., Turgunbaev U.A., Aydaralyeva D.K. The use of high-dose ifosfamide in the combined treatment of soft tissue sarcomas (first experience in the national center of oncology and hematology in bishkek). Bone and soft tissue sarcomas, tumors of the skin. 2017;(4):34-37. (In Russ.)
Views:
86
Email this article 
